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Abstract 
Purpose: To evaluate methodological and reporting quality of diagnostic accuracy 
studies of perimetry in glaucoma and to determine whether there had been any 
improvement since the publication of the Standards for Reporting of Diagnostic 
Accuracy (STARD) guidelines.  
Methods: A systematic review of English language articles published between 1993 
and 2013 reporting the diagnostic accuracy of perimetry in glaucoma. Articles were 
appraised for methodological quality using the 14-item Quality assessment tool for 
diagnostic accuracy studies (QUADAS) and evaluated for quality of reporting by 
applying the STARD checklist.  
Results: Fifty-eight articles were appraised. Overall methodological quality of these 
studies was moderate with a median number of QUADAS items rated as ‘yes’ equal to  
9 (out of a maximum of 14) (IQR 7-10).  The studies were often poorly reported; 
median score of STARD items fully reported was 11 out of 25 (IQR 10-14). A 
comparison of the studies published in 10-year periods before and after the publication 
of the STARD checklist in 2003 found quality of  reporting had not substantially 
improved. 
Conclusions: Methodological and reporting quality of diagnostic accuracy studies of 
perimetry is sub-optimal and appears not to have improved substantially following the 
development of the STARD reporting guidance. This observation is consistent with 
previous studies in ophthalmology and in other medical specialities.   
  
Introduction 
It is estimated that at least half of all glaucoma cases are undetected in developed 
countries.1 Imperfect diagnostic accuracy of current tests used to detect cases is one 
reason among others2 for this. 
There are a number of tests used for the detection and management of glaucoma, 
which involve either the assessment of structural changes to the optic nerve head, 
detection of functional visual loss by testing the visual ﬁeld (VF), or the measurement of 
the intraocular pressure (IOP). 
Standard automated perimetry (SAP) is the most frequently performed vision function 
test in patients with glaucoma or suspect glaucoma, although a variety of newer 
technologies have been introduced.3 The aim of testing the VF is to detect functional 
changes in patients with suspected disease and to monitor the progression of disease 
in those with established glaucoma. 
Diagnostic accuracy studies are used to certify new tests before they are brought into 
clinical practice. Most diagnostic accuracy studies report sensitivity and specificity, 
positive and negative predictive values, or receiver-operator characteristics (ROC) 
curves as measures of diagnostic performance.4 This information allows a clinician to 
make an informed decision regarding the potential value of the new test. However, if 
those studies are not conducted properly or their reporting is inconsistent there is 
potential for bias (internal validity) or difficulty in estimating the generalisability of the 
study findings (external validity). Furthermore, overstated or understated results could 
lead to the premature adoption of a poorly performing diagnostic test or delay the 
adoption of a high quality test respectively. Diagnostic accuracy studies in glaucoma 
present a particular problem since there is no universally agreed reference standard for 
the disease. Ophthalmologist diagnosed glaucoma following a detailed ophthalmic 
examination to detect structural and/or functional damage is the accepted reference 
standard in clinical practice.5 However, this may lead to variability in test performance 
as some patients may show evidence of structural damage without a detectable visual 
field abnormality, whilst others may have glaucomatous visual field loss without a 
detectable structural abnormality. Furthermore, studies evaluating diagnostic accuracy 
typically use a case-control design where glaucoma patients (cases) are compared 
with normal subjects (controls). The adoption of stringent inclusion and exclusion 
criteria in these studies may mean that the sample is unrepresentative of the 
population on which the test would be used in practice.  
Methodological rigour and accuracy of reporting are essential pre-requisites for the 
evaluation of diagnostic test performance. In 2003, a quality assessment tool was 
introduced for evaluating the methodological quality of diagnostic accuracy studies 
(QUADAS: Quality Assessment of Studies of Diagnostic Accuracy).6 In the same year, 
a checklist was published for improving the quality of reporting of these studies 
(STARD: Standards for the Reporting of Diagnostic accuracy studies).7 
The QUADAS tool was designed for use by those undertaking systematic reviews of 
diagnostic accuracy studies. It consists of 14 items each of which is rated as "yes", 
"no", or "unclear". The items cover the major sources of bias and to a lesser extent, the 
quality of reporting. 
The purpose of the STARD initiative was to develop a checklist to improve the quality 
of reporting of studies of diagnostic accuracy. The tool uses a list of 25 items covering 
the main sections of the paper and promoted the use of a flow diagram to present the 
study design and report the exact number of patients at each stage of the study. 
The aim of this study is to assess the methodological quality of diagnostic accuracy 
studies using a variety of perimetric tests in glaucoma, using the QUADAS tool and 
evaluate the accuracy and completeness of reporting of these studies based on the 
STARD checklist. We also sought to determine whether there had been any 
improvement in study quality and reporting since the publication of these standards.  
 
Methods 
Search strategy 
We used the OVID platform to search relevant electronic databases (MEDLINE, 
EMBASE, and Global Health) to identify diagnostic accuracy studies of perimetry 
published over a 20-year period between January 1993 and August 2013.8 The 
keywords and search terms used are described in Table 1. The search was limited to 
publications in the English language and studies on human subjects.  
 “Perimetry”* or “Perimeter”* or “Standard Automated Perimetry” or “SAP” or “visual field” or 
“Motion displacement test” or “frequency doubling technology” or “Flicker Defined Form” or 
“High pass resolution” or “HRP” or “OKP” or “Humphrey” or “Henson” or “Octopus” or 
“Heidelberg” or “Dicon” or “Medmont” or “rarebit” or “Ophthimus”. 
 
“Glaucoma”**. 
 
“Diagnostic Accuracy” or “diagnostic performance” or “precision” or “ROC” or “Receiver 
operating characteristic” or “Sensitivity and specificity” or “diagnostic odds ratio” or “DOR” or 
“area under the receiver operating characteristic curve” or “likelihood ratio”. 
“Early diagnosis” or “differentiate” or “identify” or “detect” or “diagnosis” or “screening” or 
“case finding”. 
 
 
Table 1. Key words used for the literature search 
 
* - Since the word perimeter or perimetry appears in most of the tests and synonyms of the 
test we assumed that those terms would encapsulate most forms of the test. 
**- Synonyms for the disease all tend to contain the word ‘glaucoma’ we assumed that the 
term “glaucoma” would encapsulate all forms of the disease. 
 
 
Study selection  
The titles and abstracts of all reports identified by the search strategy were screened 
by a single reviewer (BF). Full text copies of all studies deemed to be potentially 
relevant were obtained and assessed for inclusion. Reasons for exclusion at this stage 
were tabulated and any uncertainty in eligibility was resolved by discussion with the 
other members of the review team. A flow diagram of the selection process is shown in 
Figure 1.  
Assessment of methodological quality (QUADAS) and quality of reporting (STARD) 
A quality assessment was then performed on all included studies by a single reviewer 
(BF) using both quality assessment tools (QUADAS and STARD)6,7 using custom 
checklists developed in Microsoft Excel to score each quality item. A written justification 
for each decision was also included in the spreadsheet. For each of the included 
studies the diagnostic reference standard for glaucoma was documented (Table 2). 
The QUADAS tool (Table 3) is structured as a list of 14 items which are answered as 
‘yes’, ‘no’ or ‘unclear’. The items cover the main sources of bias, including:  spectrum 
bias, verification bias, disease progression bias as well as items asking about the 
execution of index and reference tests. The STARD checklist (Table 4) is divided into 5 
sections, covering the main sections of the paper: title/abstract/keywords, introduction, 
methods, results and conclusion. The majority of items in the checklist are scored as 
‘reported’, ‘not reported’ or ‘partially reported’. 
Two reviewers (JL and DC) independently assessed the quality of a random 20% 
sample of included studies. 
Journal guidance regarding the use of STARD  
We checked the ‘Instructions to Authors’ of the journals in which the articles were 
published for any advice or reference to the use of the STARD guidelines for reporting 
diagnostic accuracy studies. 
Data synthesis and statistical analysis 
Descriptive statistics were used to summarise the number and proportion of items that 
met the QUADAS and STARD criteria. Studies were stratified according to two time 
periods, 1993-2003 and 2004-2013, corresponding to periods before and after 
publication of the quality assessment tools to determine the impact of their publication 
on quality. 
An inter-rater reliability analysis using the weighted Kappa statistic was performed to 
determine consistency among reviewers.9 
 
Results 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Flow diagram showing selection process. 
 
Results from initial 
database search 
N = 488 
Full text articles 
assessed for eligibility 
N = 90 
395 studies did not match any of the 
inclusion criteria 
3 duplicates 
 
Studies excluded, with reasons 
(N=32): 
 
Not a diagnostic accuracy study = 27 
Ocular Hypertension only = 1 
Conference paper = 1 
Not Ophthalmology = 2 
Not Perimetry = 1 
Papers included in the 
analysis 
N = 58 
The initial search identified a total of 488 articles. Subsequent title and abstract 
screening excluded 398 articles that failed to meet any of the inclusion criteria. 
Following the assessment of the full text of the remaining 90 articles, a further 32 were 
excluded. Therefore, 58 studies were eligible for inclusion in the review.10-67 Inter-rater 
reliability, estimating consistency amongst the reviewers, as determined by weighted 
kappa for QUADAS and STARD was 0.70 and 0.81 respectively. The majority of 
studies used ophthalmologist diagnosis based on combined optic disc assessment, 
IOP and SAP as the reference standard for glaucoma diagnosis. 
Reference Standard 
Number of studies (%) 
Total = 58 
Optic disc examination (ODE) 3 (5.2) 
ODE+ IOP + SAP + Gonioscopy 11 (19) 
ODE + IOP + SAP 11 (19) 
ODE + IOP + SAP + (OCT or HRT or SLO or GDx) 5 (8.6) 
ODE + IOP 3 (5.2) 
ODE + SAP 8 (13.8) 
SAP 3 (5.2) 
ODE + Gonioscopy + IOP 4 (6.9) 
ODE  + Gonioscopy 1 (1.7) 
IOP + SAP 1 (1.7) 
Fundus Stereo photographs + SAP + IOP 1 (1.7) 
Fundus Stereo photographs + SAP + IOP + SLO 1 (1.7) 
Fundus Stereo photographs + SAP 1 (1.7) 
Fundus Stereo photographs + IOP 1 (1.7) 
Fundus Stereo photographs 2 (3.4) 
Optic disc photography 1 (1.7) 
Manual Suprathreshold Static Perimetry 1 (1.7) 
 
Table 2. Reference standard for glaucoma diagnosis in the included studies. 
Tables 3 and 4 summarise the results for each item using the QUADAS and STARD 
assessment tools respectively.  
Of the 58 articles, the number of QUADAS items with a ‘yes’ response ranged from 2 to 
14 with a median score of 9. For the papers published before 2003 (n=22) and after 
2003 (n=36) this median score was 8 (interquartile range [IQR] 5-9) and 10 (IQR 8-10) 
respectively. Figure 2 shows the QUADAS assessment of each article arranged 
chronologically by year of publication. 
  
  
Item 
1993 to 
2003  
(%) 
2004 to 
2013  
(%) 
Total 
(%) 
 N = 22 N = 36 N = 58 
1 Was the spectrum of patients representative of the patients 
who will receive the test in practice? 
9 (41) 16 (44) 25 (43) 
2 Were selection criteria clearly described? 18 (82) 34 (94) 52 (90) 
3 Is the reference standard likely to correctly classify the target 
condition? 
17 (77) 29 (81) 46 (79) 
4 Is the time period between reference standard and index test 
short enough to be reasonably sure that the target condition 
did not change between the two tests? 
2 (9) 21 (58) 23 (40) 
5 Did the whole sample or a random selection of the sample, 
receive verification using a reference standard of diagnosis? 
12 (55) 32 (89) 44 (76) 
6 Did patients receive the same reference standard regardless of 
the index test result? 
13 (59) 25 (69) 38 (66) 
7 Was the reference standard independent of the index test (i.e. 
the index test did not form part of the reference standard)? 21 (95) 33 (92) 54 (93) 
8 Was the execution of the index test described in sufficient 
detail to permit replication of the test? 
15 (68) 26 (72) 41 (71) 
9 Was the execution of the reference standard described in 
sufficient detail to permit its replication? 
7 (32) 24 (67) 31 (53) 
10  Were the index test results interpreted without knowledge of 
the results of the reference standard? 
4 (18) 12 (33) 16 (28) 
11 Were the reference standard results interpreted without 
knowledge of the results of the index test? 
8 (36) 19 (53) 27 (47) 
12 Were the same clinical data available when test results were 
interpreted as would be available when the test is used in 
practice? 
17 (77) 29 (81) 46 (79) 
13 Were uninterpretable/ intermediate test results reported? 6 (27) 22 (61) 28 (48) 
14 Were withdrawals from the study explained? 7 (32) 11 (31) 18 (31) 
 
Table 3. QUADAS item (scored as “Yes”) 
 
 
Figure 2. Stacked bar chart showing the QUADAS items reported and year of publication  
 
In STARD, item 2, 4 and 25 were fully reported by all 58 articles. Item 20 was not 
scored due to the non-invasive nature of perimetry. No article fulfilled all items and only 
41% reported in full more than half of the items.9 The highest and lowest number of 
items reported was 18 and 6 respectively. Statistical methods were often partially 
described and only 13 (22%) of 58 publications reported measures of statistical 
uncertainty. The median score of items fully reported was 11. For the papers published 
before 2003 (n=22) and after 2003 (n=36) this median score was 11 (interquartile 
range [IQR] 8-13) and 12.5 (IQR 10-16). Only one study explicitly mentioned the use of 
STARD for preparing the manuscript. Figure 3 shows the STARD assessment of each 
article arranged chronologically by year of publication. 
The included papers were published in 16 different journals, from those journals only 
the Archives of Ophthalmology and the British Journal of Ophthalmology encouraged 
the authors to use the STARD flow diagram and checklist for reports of diagnostic 
accuracy. We were unable to access instructions for authors for two of the included 
journals.  
Item  
1993 to 
2003 (%) 
2004 to 
2013 (%) 
Total 
(%) 
N = 22 N = 36 N = 58 
 
TITLE/ ABSTRACT 
   
1* Identify the article as a study of diagnostic accuracy 18 (82) 36 (100) 54 (93) 
 
 
INTRODUCTION    
2 State the research questions of study aims. 22 (100) 36 (100) 58 (100) 
 
 
METHODS    
3 The study population 4 (18) 12 (33) 16 (28) 
4 Participant recruitment 22 (100) 36 (100) 58 (100) 
5 Participant sampling 16 (73) 23 (64) 39 (67) 
6 Data collection strategy 8 (36) 19 (53) 27 (47) 
7 The reference standard 6 (27) 24 (67) 30 (52) 
8 Technical specifications of material and methods 13 (59) 29 (81) 42 (72) 
9 Definition of and rationale of the index tests and the 
reference standard 10 (45) 26 (72) 36 (62) 
10 The number, training and expertise of the persons 
executing and reading the tests 7 (32) 7 (19) 14 (24) 
11 Whether or not the tests were masked to the readers 2 (9) 9 (25) 11 (19) 
12$ Methods for calculating and comparing measures of 
diagnostic accuracy and uncertainty 2 (9) 3 (8) 5 (9) 
13 Methods to calculate reproducibility 1 (5) 4 (11) 5 (9) 
 
 
RESULTS    
14 When the study was done 3 (14) 12 (33) 15 (26) 
15 Clinical and demographic characteristics 13 (59) 27 (75) 40 (69) 
16 Participant flow 5 (23) 14 (39) 19 (33) 
17 Time interval between index and reference standard 3 (14) 6 (17) 9 (16) 
18 Distribution of severity of disease and other diagnoses 18 (82) 33 (92) 51 (88) 
19 Cross tabulation of the results of the index tests 12 (55) 22 (61) 34 (59) 
20 Adverse effects from performing index or reference 
tests NA NA NA 
21$ Estimates of diagnostic accuracy and measures of 
uncertainty 3 (14) 10 (28) 13 (22) 
22 How indeterminate results, missing responses and 
outliers of the index tests were handled 6 (27) 14 (39) 20 (34) 
23 ** Estimates of diagnostic accuracy between subgroups 11 (50) 19 (53) 30 (52) 
24 Estimates of test reproducibility 2 (9) 4 (11) 6 (10) 
 
 
DISCUSSION    
25 Discuss the clinical applicability of the study findings 22 (100) 36 (100) 58 (100) 
 
Table 4. STARD item (scored as “Yes”) 
 
NA - not applicable, due to the non-invasive nature of the test. 
* Considered to be positive if the words diagnostic accuracy appeared in the title or 
abstract, or if the article was identified using the MeSH term sensitivity and specificity. 
** Considered to be NA if there were no subgroups. Not applicable for 23 articles.  
$ If only estimates of diagnostic accuracy without a measure of uncertainty were given, this 
was scored as “partial.” 
 
 Figure 3. Stacked bar chart showing the STARD items reported and year of publication 
 
Discussion 
Automated perimetry is an effective tool for glaucoma diagnosis, as well as providing a 
means of monitoring disease deterioration to determine the effectiveness of treatment. 
However, a perfect diagnostic test for glaucoma does not exist, meaning that 
researchers commonly develop new tests that need to be scrutinised for diagnostic 
performance. High quality diagnostic accuracy studies are essential to evaluate test 
performance and reduce the risk of bias. The present study investigated the 
methodological quality and quality of reporting of diagnostic accuracy studies, using 
various types of perimeter to detect glaucomatous visual field loss, published between 
1993 and 2003. 
Our results showed that the overall methodological quality of these studies was low to 
moderate and they were often poorly reported. There were also differences in the 
reference standard used for glaucoma diagnosis, which could potentially lead to 
heterogeneity in test performance. A comparison of the studies published before and 
after the development of the QUADAS assessment tool and the publication of the 
STARD checklist in 2003 found that methodological quality and reporting had not 
substantially improved. These results are consistent with previous studies in 
ophthalmology 68-74 and in other medical specialities.75, 76  
QUADAS items that scored particularly poorly (rated as ‘no’ or ‘unclear’) were: item 1 
(inclusion of a representative spectrum of patients), item 4 (disease progression bias), 
item 10 (masking of reference test result) and item 14 (explanation of withdrawals). 
These sources of bias may have had a significant impact on the internal and external 
validity of the study findings reported in these papers.  
The assessment of the methodological quality of a diagnostic accuracy study is closely 
related to how well the study is reported; a well-conducted study will score poorly on a 
quality assessment tool if the methods and results are not reported in sufficient detail. 
The guiding principle of the STARD initiative is ‘to improve the accuracy and 
completeness of reporting of studies of diagnostic accuracy, to allow readers to assess 
the potential for bias in the study and to evaluate its generalisability’.7 The checklist 
consists of 25 items that roughly follow the structure of a journal article (Title/abstract, 
Introduction, Methods, Results and Discussion). The average number of items fully 
reported prior to the introduction of STARD was 9.2 (36.8%) compared to 12.8 (51.2%) 
for the period after publication. Only 3 items were fully reported by all studies including: 
study aims, method of participant recruitment and discussion of the clinical applicability 
of the study findings. Significant omissions included a full description of the study 
population in terms of inclusion and exclusion criteria (STARD item 3), which was 
reported by only 28% of studies. This is important for the assessment of the potential 
for spectrum bias which may impact on test performance and the applicability of the 
study findings. For example, tests with diagnostic promise normally become more 
sensitive as a disease becomes more severe; a study including participants with 
advanced disease only would by default report better sensitivity. Very few articles 
(19%) reported if the investigators are masked to the results of the other tests (STARD 
item 11). There is the possibility of inflation of the diagnostic accuracy estimates if 
readers of one test are aware of the results of either the reference standard or other 
clinical information when interpreting the index test. Whilst the majority of articles 
reported estimates of diagnostic accuracy, typically as sensitivities and specificities, 
only 22% of studies fully provided measures of statistical uncertainty e.g. confidence 
intervals. Only a third of the articles reported how withdrawals (STARD item 16) and 
indeterminate or missing results were handled (STARD item 22). 
Over the past 20 years, a number of reporting guidelines have been developed to 
assist health researchers in writing up their work for publication, by specifying a 
minimum set of items that are required to provide a transparent account of what was 
done together with a clear description of the results of the study. The most widely 
known guidelines include the CONSORT statement for reporting parallel group 
randomised controlled trials, the STROBE statement for observational studies and the 
PRISMA statement for authors of systematic reviews (see the EQUATOR network for a 
full description of these guidelines).77 Although an increase in reporting quality has 
been observed following the introduction of these guidelines, their adoption has been 
slow.78 However, journal endorsement of the reporting guideline may improve the 
completeness of reporting.78 Only one of the articles included in the current review 
mentioned the use of STARD in the preparation of the manuscript and only two of the 
16 journals in which these articles were published made reference to STARD in their 
‘Instructions to Authors’.   
Conclusions 
The major strength of this study was the comprehensive search strategy used, along 
with rigorous methods for study selection and quality appraisal. Both QUADAS and 
STARD checklists were examined, which provide a complementary assessment of both 
methodological quality and quality of reporting. The overall conclusion is that the quality 
of reporting of the diagnostic accuracy of perimetric tests in glaucoma is sub-optimal 
and appears not to have improved substantially following the development of the 
STARD initiative. Adoption and enforcement of STARD by ophthalmic journals is likely 
to lead to quality improvements in reporting of these studies.  
 
References 
1. Quigley, HA. The number of people with glaucoma worldwide in 2010 and 2020. Br 
J Ophthalmol  2006; 90: 262–7. 
2. Prior M, Francis JJ, Azuara-Blanco A, Anand N, Burr JM; Glaucoma screening 
Platform Study group. Why do people present late with advanced glaucoma? A 
qualitative interview study.Br J Ophthalmol  2013;97:1574-8.  
3. Jampel, HD, Singh, K, Lin, SC, Chen, TC, Francis, BA, Hodapp, E, Samples, JR, 
Smith, SD.Assessment of visual function in glaucoma: a report by the American 
Academy of Ophthalmology. Ophthalmology 2011; 118:986-1002.  
4. Deeks, JJ. Systematic reviews in health care: Systematic reviews of evaluations of 
diagnostic and screening tests. BMJ 2001; 323:157–62.  
5. Mowatt G, Burr JM, Cook JA, Siddiqui MAR, Ramsay C, Fraser C, et al. Screening 
Tests for Detecting Open-Angle Glaucoma: Systematic Review and Meta-analysis. 
Investigative Ophthalmology & Visual Science. 2008 Dec 1;49(12):5373–85. 
6. Whiting, P, Rutjes, AW, Reitsma, JB, Bossuyt, PM, Kleijnen, J. The development of 
QUADAS: a tool for the quality assessment of studies of diagnostic accuracy 
included in systematic reviews. BMC Med Res Methodol  2003; 3: 25. 
7. Bossuyt, PM, Reitsma, JB, Bruns, DE, Gatsonis, CA, Glasziou, PP, Irwig, LM, 
Lijmer, JG, Moher, D, Rennie, D, de Vet, HC. Towards complete and accurate 
reporting of studies of diagnostic accuracy: the STARD initiative. Standards for 
Reporting of Diagnostic Accuracy. Clin Chem 2003; 49:1-6.  
8. Deville, WL, Bezemer, PD, Bouter, LM. Publications on diagnostic test evaluation in 
family medicine journals: an optimal search strategy. J Clin Epidemiol 2000; 53:65–
9. 
9. Landis, JR, Koch, GG. The measurement of observer agreement for categorical 
data. Biometrics 1977; 33:159-174. 
10. Wishart, PK. Oculokinetic perimetry compared with Humphrey visual field analysis 
in the detection of glaucomatous visual field loss. Eye (Lond) 1993; 7:113–21.  
11. Mutlukan, E, Damato, BE, Jay, JL. Clinical evaluation of a multi-fixation campimeter 
for the detection of glaucomatous visual field loss. Br J Ophthalmol 1993;77:332–8.  
12. Katz, J, Tielsch, JM, Quigley, HA, Javitt, J, Witt, K, Sommer, A. Automated 
suprathreshold screening for glaucoma: the Baltimore Eye Survey. Invest 
Ophthalmol Vis Sci 1993; 34: 3271–7.  
13. Adachi, M, Shirato, S. The usefulness of the Noise-Field Test as a screening 
method for visual field defects. Jpn J Ophthalmol 1994; 38: 392–9.  
14. Christoffersen, T, Fors, T, Waage, S, Holtedahl, K. Glaucoma screening with 
oculokinetic perimetry in general practice: is its specificity acceptable? Eye (Lond). 
1995; 9: 36–9.  
15. Sponsel, WE, Ritch, R, Stamper, R, Higginbotham, EJ, Anderson, DR, Wilson, MR, 
Zimmerman, TJ. Prevent Blindness America visual field screening study. The 
Prevent Blindness America Glaucoma Advisory Committee. Am J Ophthalmol 
1995;120: 699–708.  
16. Graham, SL, Drance, SM, Chauhan, BC, Swindale, NV, Hnik, P, Mikelberg, FS, 
Douglas, GR. Comparison of psychophysical and electrophysiological testing in 
early glaucoma. Invest Ophthalmol Vis Sci 1996; 37: 2651–62.  
17. Huang, AS, Smith, SD, Quigley, HA. The efficacy of the Dicon screening field to 
detect eyes with glaucomatous field loss by Humphrey threshold testing. J 
Glaucoma 1998;7:158–64.  
18. Bosworth, CF, Sample, PA, Gupta. N, Bathija, R, Weinreb, RN. Motion automated 
perimetry identifies early glaucomatous field defects. Arch Ophthalmol 
1998;116:1153–8.  
19. Sim, DH, Goh, LG. Screening for glaucoma in the Chinese elderly population in 
Singapore. Singapore Med J 1999; 40: 644–7.  
20. Yamada, N, Chen, PP, Mills, RP, Leen, MM, Lieberman, MF, Stamper, RL, 
Stanford, DC. Screening for glaucoma with frequency-doubling technology and 
Damato campimetry. Arch Ophthalmol  1999 ;117:1479–84.  
21. Fabré, K, Michiels, I, Zeyen, T. The sensitivity and specificity of TOP, FDP and 
GDX in screening for early glaucoma. Bull Soc Belge Ophtalmol 2000;275:17–23.  
22. Burnstein, Y, Ellish, NJ, Magbalon, M, Higginbotham, EJ. Comparison of frequency 
doubling perimetry with Humphrey visual field analysis in a glaucoma practice. Am 
J Ophthalmol  2000;129: 328–33.  
23. Cello, KE, Nelson-Quigg, JM, Johnson, CA. Frequency doubling technology 
perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol  
2000;129: 314–22.  
24. Trible, JR, Schultz, RO, Robinson, JC, Rothe, TL. Accuracy of glaucoma detection 
with frequency-doubling perimetry. Am J Ophthalmol  2000;129:740–5.  
25. Vitale, S, Smith, TD, Quigley, T, Kerrigan-Baumrind, TA, Pease, TE, Varma, R, 
Friedman, TS, Katz, J, Tielsch, JM. Screening performance of functional and 
structural measurements of neural damage in open-angle glaucoma: a case-control 
study from the Baltimore Eye Survey. J Glaucoma 2000; 9:346–56.  
26. Paczka, JA, Friedman, DS, Quigley, HA, Barron, Y, Vitale, S. Diagnostic 
capabilities of frequency-doubling technology, scanning laser polarimetry, and 
nerve fiber layer photographs to distinguish glaucomatous damage. Am J 
Ophthalmol  2001;131:188–97.  
27. Wadood, AC, Azuara-Blanco, A, Aspinall, P, Taguri, A, King, AJ. Sensitivity and 
specificity of frequency-doubling technology, tendency-oriented perimetry, and 
Humphrey Swedish interactive threshold algorithm-fast perimetry in a glaucoma 
practice. Am J Ophthalmol  2002;133:327–32.  
28. Bayer, AU, Maag, K-P, Erb, C. Detection of optic neuropathy in glaucomatous eyes 
with normal standard visual fields using a test battery of short-wavelength 
automated perimetry and pattern electroretinography. Ophthalmology 
2002;109:1350–61.  
29. Horn, FK, Wakili, N, Jünemann, AM, Korth, M. Testing for glaucoma with 
frequency-doubling perimetry in normals, ocular hypertensives, and glaucoma 
patients. Graefes Arch Clin Exp Ophthalmol 2002; 240:658–65.  
30. Iwasaki, A, Sugita, M. Performance of glaucoma mass screening with only a visual 
field test using frequency-doubling technology perimetry. Am J Ophthalmol 
2002;134: 529–37.  
31. Horn, FK, Nguyen, NX, Mardin, CY, Jünemann, AG. Combined use of frequency 
doubling perimetry and polarimetric measurements of retinal nerve fiber layer in 
glaucoma detection. Am J Ophthalmol  2003;135:160–8.  
32. Detry-Morel, M, Zeyen, T, Kestelyn, P, Collignon, J, Goethals, M. Screening for 
glaucoma in a general population with the non-mydriatic fundus camera and the 
frequency doubling perimeter. Eur J Ophthalmol 2004;14:387–93.  
33. Spry, PG, Johnson, CA, Mansberger, SL, Cioffi, GA. Psychophysical investigation 
of ganglion cell loss in early glaucoma: J Glaucoma. 2005;14:11–9.  
34. Brusini, P. Probing glaucoma visual damage by rarebit perimetry. Br J Ophthalmol 
2005; 89:180–4.  
35. Heeg, GP, Blanksma, LJ, Hardus, PLLJ, Jansonius, NM. The Groningen 
Longitudinal Glaucoma Study. I. Baseline sensitivity and specificity of the frequency 
doubling perimeter and the GDx nerve fibre analyser: Acta Ophthalmologica 2005; 
83:46–52.  
36. Mansberger, SL, Johnson, CA, Cioffi, GA, Choi, D, Krishnadas, SR, Srinivasan, M, 
et al. Predictive value of Frequency Doubling Technology perimetry for detecting 
glaucoma in a developing country. J Glaucoma 2005; 14:128–34.  
37. Babalola, OE. The motion sensitivity screening test in clinical practice in abuja, 
Nigeria: affordable automated perimetry for the third world? Afr J Med Med Sci 
2005; 34:119–24.  
38. Robin, TA, Müller, A, Rait, J, Keeffe, JE, Taylor, HR, Mukesh, BN. Performance of 
community-based glaucoma screening using Frequency Doubling Technology and 
Heidelberg Retinal Tomography. Ophthalmic Epidemiol 2005;12:167–78.  
39. Fogagnolo, P, Mazzolani, F, Rossetti, L, Orzalesi, N. Detecting glaucoma with 
Frequency Doubling Technology perimetry: A comparison between N-30 and C-20 
screening programs. J Glaucoma  2005;14:485–91.  
40. Matsumoto, C, Takada, S, Okuyama, S, Arimura, E, Hashimoto, S, Shimomura, Y. 
Automated flicker perimetry in glaucoma using Octopus 311: a comparative study 
with the Humphrey Matrix. Acta Ophthalmologica  2006;84:210–5.  
41. Brusini, P, Salvetat, ML, Zeppieri, M, Parisi, L. Frequency Doubling Technology 
perimetry with the Humphrey Matrix 30-2 test, J Glaucoma  2006 Apr;15(2):77–83.  
42. Pierre-Filho, P, Schimiti, RB, De Vasconcellos, JPC, Costa, VP. Sensitivity and 
specificity of Frequency Doubling Technology, tendency-oriented perimetry, SITA 
Standard and SITA Fast perimetry in perimetrically inexperienced individuals. Acta 
Ophthalmologica 2006;84:345–50.  
43. North, RV, Jones, AL, Hunter, E, Morgan, JE, Wild, JM. Evaluation of the high 
specificity Screening Program (C-20-1) of the Frequency Doubling Technology 
(FDT) perimeter in clinical practice. Eye 2006; 20:681–7.  
44. Gardiner, SK, Anderson, DR, Fingeret, M, McSoley, JJ, Johnson, CA. Evaluation of 
decision rules for Frequency Doubling Technology screening tests. Optom Vis Sci 
2006; 83: E432–E439.  
45. Sample, PA, Medeiros, FA, Racette, L, Pascual, JP, Boden, C, Zangwill, LM, Bowd, 
C, Weinreb, RN. Identifying glaucomatous vision loss with visual-function-specific 
perimetry in the diagnostic innovations in glaucoma study. Invest Ophthalmol Vis 
Sci  2006; 47:3381–9.  
46. Iwase, A, Tomidokoro, A, Araie, M, Shirato, S, Shimizu, H, Kitazawa, Y. 
Performance of Frequency Doubling Technology Perimetry in a population-based 
prevalence survey of glaucoma. Ophthalmology 2007;114: 27–32.  
47. Leeprechanon, N, Giangiacomo, A, Fontana, H, Hoffman, D, Caprioli, J. Frequency 
Doubling Perimetry: Comparison with Standard Automated Perimetry to detect 
glaucoma. Am J Ophthalmol  2007;143:263–271.  
48. Fortune, B, Demirel, S, Zhang, X, Hood, DC, Patterson, E, Jamil, A, Mansberger, 
SL, Cioffi, GA, Johnson, CA. Comparing multifocal VEP and standard automated 
perimetry in high-risk ocular hypertension and early glaucoma. Invest Ophthalmol 
Vis Sci 2007;48:1173–80.  
49. Kumar, S, Giubilato, A, Morgan, W, Jitskaia, L, Barry, C, Bulsara, M, Constable, IJ, 
Yogesan, K. Glaucoma screening: analysis of conventional and telemedicine-
friendly devices. Clin  Exp Ophthalmol 2007; 35:237–43.  
50. Leeprechanon, N, Giaconi, JA, Manassakorn, A, Hoffman, D, Caprioli, J. Frequency 
Doubling perimetry and short-wavelength automated perimetry to detect early 
glaucoma. Ophthalmology 2007;114:931–7.  
51. Ferreras, A, Polo, V, Larrosa, JM, Pablo, LE, Pajarin, AB, Pueyo, V, Honrubia, FM. 
Can Frequency Doubling Technology and Short-wavelength Automated Perimetries 
detect visual field defects before Standard Automated Perimetry in patients with 
preperimetric glaucoma? J Glaucoma 2007;16:372–83.  
52. Horn FK, Brenning A, Junemann AG, Lausen B. Glaucoma Detection With 
Frequency Doubling Perimetry and Short-wavelength Perimetry: Journal of 
Glaucoma. 2007 Jun;16(4):363–71.  
53. Tóth, M, Kothy, P, Vargha, P, Hollo, G. Accuracy of combined GDx-VCC and Matrix 
FDT in a glaucoma screening trial: J Glaucoma  2007;16:462–70.  
54. Wang, YX, Xu, L, Zhang, RX, Jonas, JB. Frequency-doubling threshold perimetry in 
predicting glaucoma in a population-based study: The Beijing Eye Study. Arch 
Ophthalmol  2007;125:1402–6.  
55. Spry, PGD, Hussin, HM, Sparrow, JM. Performance of the 24-2-5 Frequency 
Doubling Technology screening test: a prospective case study. Br J Ophthalmol 
2007;91:1345–9.  
56. Tafreshi, A, Sample, PA, Liebmann, JM, Girkin, CA, Zangwill, LM, Weinreb, RN, et 
al. Visual function-specific perimetry to identify glaucomatous visual loss using 
three different definitions of visual field abnormality. Invest Ophthalmol Vis Sci 
2009; 50:1234–40.  
57. Salim, S, Netland, PA, Fung, KH, Smith, ME, Aldridge, A. Assessment of the 
Student Sight Savers Program methods for glaucoma screening. Ophthalmic 
Epidemiol  2009;16:238–42.  
58. Cook, C, Cockburn, N, van der Merwe, J, Ehrlich, R. Cataract and glaucoma case 
detection for Vision 2020 programs in Africa: An evaluation of 6 possible screening 
tests. J Glaucoma 2009;18:557–62.  
59. Racette, L, Chiou, CY, Hao, J, Bowd, C, Goldbaum, MH, Zangwill, LM, Lee, TW, 
Weinreb, RN, Sample, PA. Combining functional and structural tests improves the 
diagnostic accuracy of relevance vector machine classifiers. J Glaucoma 
2010;19:167–75.  
60. Salvetat, ML, Zeppieri, M, Tosoni, C, Parisi, L, Brusini, P. Non-conventional 
perimetric methods in the detection of early glaucomatous functional damage. Eye 
2010;24:835–42.  
61. Rowe, FJ, Sueke, H, Gawley, SD. Comparison of Damato campimetry and 
Humphrey automated perimetry results in a clinical population. Br J Ophthalmol 
2010; 94:757–62.  
62. Zhong, Y, Zhou, X, Cheng, Y, Xie, L. Relation between blue-on-yellow perimetry 
and optical coherence tomography in normal tension glaucoma. Can J Ophthalmol  
2010;45:494–500.  
63. Kamdeu Fansi, AA, Li, G, Harasymowycz, PJ. The validity of screening for open-
angle glaucoma in high-risk populations with single-test screening mode Frequency 
Doubling Technology perimetry (FDT). J Glaucoma  2011; 20:167–71.  
64. Francis, BA, Varma, R, Vigen, C, Lai, MY, Winarko, J, Nguyen, B, Azen, S, Los 
Angeles Latino Eye Study Group. Population and high-risk group screening for 
glaucoma: The Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 2011; 
52:6257–64.  
65. Gonzalez de la Rosa, M. Pulsar perimetry in the diagnosis of early glaucoma. Am J 
Ophthalmol  2011;152: 500–1.  
66. Horn, FK, Lämmer, R, Mardin, CY, Jünemann, AG, Michelson, G, Lausen, B, Adler, 
W. Combined evaluation of Frequency Doubling Technology perimetry and 
scanning laser ophthalmoscopy for glaucoma detection using automated 
classification. J Glaucoma  2012;21:27–34.  
67. Anton, A, Capilla, P, Morilla-Grasa, A, Luque, MJ, Artigas, JM, Felipe, A. 
Multichannel functional testing in normal subjects, glaucoma suspects, and 
glaucoma patients. Invest Ophthalmol Vis Sci 2012; 53:8386–95.  
68. Siddiqui, MA, Azuara-Blanco, A, Burr, J. The quality of reporting of diagnostic 
accuracy studies published in ophthalmic journals. Br J Ophthalmol 2005; 89:261-5. 
69. Shunmugam, M, Azuara-Blanco, A. The quality of reporting of diagnostic accuracy 
studies in glaucoma using the Heidelberg retina tomograph. Invest Ophthalmol Vis 
Sci 2006; 47: 2317–23 
70. Johnson, ZK, Siddiqui, MAR, Azuara-Blanco, A. The quality of reporting of 
diagnostic accuracy studies of optical coherence tomography in glaucoma. 
Ophthalmology 2007;114:1607-12. 
71. Paranjothy, B, Shunmugam, M, Azuara-Blanco, A. The quality of reporting of 
diagnostic accuracy studies in glaucoma using scanning laser polarimetry. J 
Glaucoma  2007;16:670-5.  
72. Zafar, A, Khan, GI, Siddiqui, MA. The quality of reporting of diagnostic accuracy 
studies in diabetic retinopathy screening: a systematic review. Clin Experiment 
Ophthalmol 2008;36:537-42.  
73. Castillo, MM, Mowatt, G, Lois, N, Elders, A, Fraser, C, Amoaku, W, Burr, JM, 
Lotery, AJ, Ramsay, CR, Azuara-Blanco, A. Optical coherence tomography for the 
diagnosis of neovascular age-related macular degeneration: a systematic review. 
Eye (Lond). 2014;28:1399-1406.   
74. Harper R, Reeves B. Compliance with methodological standards when evaluating 
ophthalmic diagnostic tests. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1650–7. 
75. Coppus, SF, van der Veen, F, Bossuyt, PM, Mol, BW. Quality of reporting of test 
accuracy studies in reproductive medicine: impact of the Standards for Reporting of 
Diagnostic Accuracy (STARD) initiative. Fertil Steril 2006;86:1321-9. 
76. Wilczynski, NL. Quality of reporting of diagnostic accuracy studies: no change since 
STARD statement publication--before-and-after study. Radiology 2008; 248:817-
23.  
77. The EQUATOR Network. www.equator-network.org/ (accessed 3.1.15) 
78. Turner, L, Shamseer, L, Altman, DG, Weeks, L, Peters J, Kober, T, Dias,S, Schulz, 
KF, Plint, AC, Moher, D. Consolidated standards of reporting trials (CONSORT) 
and the completeness of reporting of randomised controlled trials (RCTs) published 
in medical journals. Cochrane Database Syst Rev 2012;11: MR000030. 
  
Acknowledgements 
The authors thank Optovue Inc. for part-funding a PhD studentship for Bruno Fidalgo  
 
Disclosure 
The authors report no conflicts of interest  
 
Figure captions 
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Figure 2. Stacked bar chart showing the QUADAS items reported and year of 
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